Abstract
Purpose
Patients with cancer spend significant time receiving treatment and recovering from side effects. Little is known about how patients and their caregivers perceive time spent receiving cancer treatment and how this impacts health-related quality of life (HRQoL). Our study aims to characterize perceptions of time invested in receiving cancer therapy as experienced by patients, caregivers, and oncology professionals.
Methods
We conducted semi-structured interviews with patients undergoing treatment for advanced lung cancer and melanoma, their informal caregivers, and oncology professionals (physicians, nurses, social workers, and chaplains). Participants received and provided care at a tertiary cancer center. Interviews were audiorecorded and transcribed verbatim. Transcripts were analyzed qualitatively using predominantly inductive coding to identify themes relating to time perception and cancer care.
Results
We interviewed 29 participants (11 patients, 7 informal caregivers, and 11 oncology professionals) and found they consistently differentiated between time remaining in life (“existential time”) and time required to manage cancer treatment and symptoms (“chronological time”). Patients and caregivers reported distress around the mechanics of oncologic care that interrupted their daily lives (hobbies, activities). Participants described the impact of time invested in cancer care on dimensions of quality of life, ranging from minimal to substantial negative impact.
Conclusions
We found that the time spent undergoing cancer treatment affects well-being and often prevents patients and caregivers from participating in meaningful activities. The investment of personal time undergoing cancer therapy for patients with advanced solid tumors merits further study and can enhance communication between patients, caregivers, and their oncologists.
Similar content being viewed by others
References
Cardoso G, Graca J, Klut C, Trancas B, Papoila A (2015) Depression and anxiety symptoms following cancer diagnosis: a cross-sectional study. Psychol Health Med 8506(April):1–9.
Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S (2001) The prevalence of psychological distress by cancer site. Psychooncology 10(1):19–28
Jayadevappa R, Malkowicz SB, Chhatre S, Johnson JC, Gallo JJ (2012) The burden of depression in prostate cancer. Psychooncology 21(12):1338–1345
Litzelman K, Kent EE, Mollica M, Rowland JH (2016) How does caregiver well-being relate to perceived quality of care in patients with cancer? Exploring associations and pathways. J Clin Oncol 34(29):3554–3561
Yabroff KR, Davis WW, Lamont EB, Fahey A, Topor M, Brown ML, Warren JL (2007) Patient time costs associated with cancer care. J Natl Cancer Inst 99(1):14–23
Bange EM, Doucette A, Gabriel PE, Porterfield F, Harrigan JJ, Wang R, Wojcieszynski AP, Boursi B, Mooney BI, Reiss KA, Mamtani R (2020) Opportunity costs of receiving palliative chemotherapy for metastatic pancreatic ductal adenocarcinoma. JCO Oncol Pract 16:e678–e687. https://doi.org/10.1200/JOP.19.00328
Yabroff KR, Kim Y (2009) Time costs associated with informal caregiving for cancer survivors. Cancer 115(SUPPL. 18):4362–4373
Kim Y, Spillers RL (2010) Quality of life of family caregivers at 2 years after a relative’s cancer diagnosis. Psychooncology 19(4):431–440
Kim Y, Spillers RL, Hall DL (2012) Quality of life of family caregivers 5 years after a relative’s cancer diagnosis: follow-up of the national quality of life survey for caregivers. Psychooncology 21(3):273–281
Yabroff KR, Warren JL, Knopf K, Davis WW, Brown ML (2005) Estimating patient time costs associated with colorectal cancer care. Med Care 43(7):640–648
Yabroff KR, Guy GP Jr, Ekwueme DU, McNeel T, Rozjabek HM, Dowling E, Li C, Virgo KS (2014) Annual patient time costs associated with medical care among cancer survivors in the United States. Med Care 52(7):594–601
Temel JS, Shaw AT, Greer JA (2016) Challenge of prognostic uncertainty in the modern era of cancer therapeutics. J Clin Oncol 34(30):3605–3608
QSR International Pty Ltd. (2018) NVivo (Version 12), https://www.qsrinternational.com/nvivo-qualitative-data-analysis-software/home
Creswell JW, Poth CN (2018) Qualitative inquiry and research design: choosing among five approaches, Fourth edn. SAGE, Los Angeles
Saldana J (2016) The coding manual for qualitative researchers, 3rd edn. SAGE, Thousand Oaks
Karlsson M, Friberg F, Wallengren C, Öhlén J (2014) Meanings of existential uncertainty and certainty for people diagnosed with cancer and receiving palliative treatment: a life-world phenomenological study. BMC Palliat Care 13:28
Heidegger M, Macquarrie J, Robinson E (1962) Being and time. Blackwell, Malden
Jabloo VG, Alibhai SMH, Fitch M, Tourangeau AE, Ayala AP, Puts MTE (2017) Antecedents and outcomes of uncertainty in older adults with cancer: a scoping review of the literature. Oncol Nurs Forum. Oncology Nursing Society 44:E152–E167
Varner S, Lloyd G, Ranby KW, Callan S, Robertson C, Lipkus IM (2019) Illness uncertainty, partner support, and quality of life: a dyadic longitudinal investigation of couples facing prostate cancer. Psychooncology. 28(11):2188–2194
Brown P, de Graaf S (2013) Considering a future which may not exist: the construction of time and expectations amidst advanced-stage cancer. Health Risk Soc 15(6–7):543–560
Granek L, Nakash O, Ariad S, Shapira S, Ben-David MA (2019) Oncology health care professionals’ perspectives on the causes of mental health distress in cancer patients. Psychooncology. 28(8):1695–1701
Loh KP, Mohile SG, Lund JL, Epstein R, Lei L, Culakova E et al (2019) Beliefs about advanced cancer curability in older patients, their caregivers, and oncologists. Oncologist 24(6):e292–e302
Shin DW, Cho J, Kim SY, Yang HK, Park K, Kweon SS, Koh DH, Nam HS, Park JH (2018) Patients’ and family caregivers’ understanding of the cancer stage, treatment goal, and chance of cure: a study with patient-caregiver-physician triad. Psychooncology. 27(1):106–113
Gramling R, Fiscella K, Xing G, Hoerger M, Duberstein P, Plumb S et al (2016) Determinants of patient-oncologist prognostic discordance in advanced cancer. JAMA Oncol 2(11):1421–1426
Tang ST, Chang WC, Chen JS, Chou WC, Hsieh CH, Chen CH (2016) Associations of prognostic awareness/acceptance with psychological distress, existential suffering, and quality of life in terminally ill cancer patients’ last year of life. Psychooncology. 25(4):455–462
Weeks JC, Catalano PJ, Cronin A, Finkelman MD, Mack JW, Keating NL, Schrag D (2012) Patients’ expectations about effects of chemotherapy for advanced cancer. N Engl J Med 367(17):1616–1625
Breitbart W, Pessin H, Rosenfeld B, Applebaum AJ, Lichtenthal WG, Li Y, Saracino RM, Marziliano AM, Masterson M, Tobias K, Fenn N (2018) Individual meaning-centered psychotherapy for the treatment of psychological and existential distress: a randomized controlled trial in patients with advanced cancer. Cancer. 124(15):3231–3239
Spiegel D (2015) Existential psychotherapy for patients with advanced cancer: facing the future and the past. J Clin Oncol 33(24):2713–2714
Chochinov HM, Hack T, Hassard T, Kristjanson LJ, McClement S, Harlos M (2005) Dignity therapy: a novel psychotherapeutic intervention for patients near the end of life. J Clin Oncol 23(24):5520–5525
Periyakoil VS, Neri E, Kraemer H (2018) Common items on a bucket list. J Palliat Med 21(5):652–658
Tarbi EC, Meghani SH (2019) A concept analysis of the existential experience of adults with advanced cancer. Nurs Outlook 67(5):540–557
Vehling S, Kissane DW (2018) Existential distress in cancer: alleviating suffering from fundamental loss and change. Psychooncology. 27(11):2525–2530
Coyle N (2006) The hard work of living in the face of death. J Pain Symptom Manag 32(3):266–274
Brown RF, Shuk E, Leighl N, Butow P, Ostroff J, Edgerson S, Tattersall M (2011) Enhancing decision making about participation in cancer clinical trials: development of a question prompt list. Support Care Cancer 19(8):1227–1238
Clayton JM, Butow PN, Tattersall MHN, Devine RJ, Simpson JM, Aggarwal G, Clark KJ, Currow DC, Elliott LM, Lacey J, Lee PG, Noel MA (2007) Randomized controlled trial of a prompt list to help advanced cancer patients and their caregivers to ask questions about prognosis and end-of-life care. J Clin Oncol 25(6):715–723
Paladino J, Bernacki R, Neville BA, Kavanagh J, Miranda SP, Palmor M, Lakin J, Desai M, Lamas D, Sanders JJ, Gass J, Henrich N, Lipsitz S, Fromme E, Gawande AA, Block SD (2019) Evaluating an intervention to improve communication between oncology clinicians and patients with life-limiting cancer: a cluster randomized clinical trial of the serious illness care program. JAMA Oncol 5(6):801–809
Funding
The Stanford Cancer Institute Survivorship program provided financial support for the study to support gift card reimbursement for patients and transcription services.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study was approved by the Stanford University Institutional Review Board.
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 20 kb).
Rights and permissions
About this article
Cite this article
Hall, E.T., Sridhar, D., Singhal, S. et al. Perceptions of time spent pursuing cancer care among patients, caregivers, and oncology professionals. Support Care Cancer 29, 2493–2500 (2021). https://doi.org/10.1007/s00520-020-05763-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-020-05763-9